A prospective controlled study of neurodevelopment in HIV-uninfected children exposed to combination antiretroviral drugs in pregnancy.
about
Neurodevelopment: The Impact of Nutrition and Inflammation During Early to Middle Childhood in Low-Resource Settings.Antiretroviral drugs for preventing mother-to-child transmission of HIV in sub-Saharan Africa: balancing efficacy and infant toxicity.Neurodevelopment and in utero antiretroviral exposure of HIV-exposed uninfected infants.Progressive mitochondrial compromise in brains and livers of primates exposed in utero to nucleoside reverse transcriptase inhibitors (NRTIs)Safety of in utero and neonatal antiretroviral exposure: cognitive and academic outcomes in HIV-exposed, uninfected children 5-13 years of age.Brain Imaging and Neurodevelopment in HIV-uninfected Thai Children Born to HIV-infected MothersLaboratory Abnormalities Among HIV-Exposed, Uninfected Infants: IMPAACT Protocol P1025Atazanavir exposure in utero and neurodevelopment in infants: a comparative safety study.Safety of perinatal exposure to antiretroviral medications: developmental outcomes in infants.Developmental delay and behavioral disorders in 59 HIV-exposed uninfected infants.Antiretroviral Treatment in HIV-1-Positive Mothers: Neurological Implications in Virus-Free ChildrenAntiretroviral use during pregnancy for treatment or prophylaxis.A systematic review of psychological functioning of children exposed to HIV: using evidence to plan for tomorrow's HIV needs.Adverse drug reactions associated with antiretroviral therapy during pregnancy.Community-Based Needs Assessment of Neurodevelopment, Caregiver, and Home Environment Factors in Young Children Affected by HIV in Lima, Peru.Neurodevelopment of HIV-Exposed and HIV-Unexposed Uninfected Children at 24 Months.Longitudinal development of cognitive, visuomotor and adaptive behavior skills in HIV uninfected children, aged 3-5 years of age, exposed pre- and perinatally to anti-retroviral medications.Development assessment of HIV exposed children aged 6-18 months: a cohort study from North India.Anthropometric Parameters of HIV-Infected and HIV-Uninfected Mothers and their Premature Infants.Perinatal exposure to antiretroviral therapy is associated with increased blood mitochondrial DNA levels and decreased mitochondrial gene expression in infants.Neurodevelopmental outcome of HIV-exposed but uninfected infants in the Mother and Infants Health Study, Cape Town, South Africa.Quality of caregiving is positively associated with neurodevelopment during the first year of life among HIV-exposed uninfected children in Uganda.The burden and predictors of cognitive impairment among 6- to 8-year-old children infected and uninfected with HIV from Harare, Zimbabwe: a cross-sectional study.In utero exposure to antiretrovirals and neurodevelopment among HIV-exposed uninfected children in Botswana.Perinatal HIV Infection or Exposure Is Associated With Low N-Acetylaspartate and Glutamate in Basal Ganglia at Age 9 but Not 7 Years.
P2860
Q30145548-4475F9C4-ED2E-4CBB-9597-D31804BC4C3AQ33897042-5F0DE9D6-629B-4D68-A91A-7D7910677268Q34181048-37D05AA6-FA9A-4C87-A626-53BB1B5189D8Q34200645-6D1EB72E-FFEC-44AE-870D-C43351600D11Q34440361-C0ABCD15-7469-4000-96BF-C1BAFE185624Q36073155-A1272D65-2ADA-4053-9057-A4A26A36E7A4Q36851168-AE41E25B-B1CC-4B97-96C7-09C9746A4489Q36853210-33F9A56F-256E-4E6D-8ABB-3F51B1184516Q37045192-9D92E863-6BCB-4BFC-8146-C2B84AF8B670Q37597830-EC4E31D4-5F77-4356-8739-7F52218D9E74Q37691000-54D00D4F-9FA8-457D-847F-85850C3A9DD7Q37870932-A977C34A-BA13-47D0-9290-D0A34306C48BQ38204304-0181BBC8-E850-4B3E-82A3-388F3A03CA76Q38267557-7C3E8A35-BF67-4673-9697-CE9FCFBDAD88Q39966915-C044C51F-B3A7-4425-BD41-27FE2950FFABQ40040103-6C4EE9E0-9F19-4C64-A2A1-34C7C8B9D8A9Q40221645-6DEC8E35-1650-490B-9520-EF8DCABAADF3Q40300667-6459DC88-D4E3-45BA-BA69-5189D90D80B4Q41922802-E537A0DD-F384-49C3-983E-86D536E8E32FQ44097186-1015CE89-F112-4FBA-932E-C5508D0A7B7FQ46868578-135C3EA6-BF0A-4748-A397-9AC0618B8BCCQ47180418-D52EFB2A-A1E8-43FD-A046-8782C6397FBBQ50734949-090FA449-E1C6-421B-886B-5148097B4A94Q51365493-8DD25422-67CC-435D-890B-437C53DD6F51Q55113867-08492D82-7866-4D7E-B1B8-FE194420AF78
P2860
A prospective controlled study of neurodevelopment in HIV-uninfected children exposed to combination antiretroviral drugs in pregnancy.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
A prospective controlled study ...... retroviral drugs in pregnancy.
@en
A prospective controlled study ...... retroviral drugs in pregnancy.
@nl
type
label
A prospective controlled study ...... retroviral drugs in pregnancy.
@en
A prospective controlled study ...... retroviral drugs in pregnancy.
@nl
prefLabel
A prospective controlled study ...... retroviral drugs in pregnancy.
@en
A prospective controlled study ...... retroviral drugs in pregnancy.
@nl
P2093
P356
P1433
P1476
A prospective controlled study ...... retroviral drugs in pregnancy.
@en
P2093
David R Burdge
Deborah M Money
Evelyn Maan
John C Forbes
Lesley J Cole
Michael P Papsdorf
Ruth E Grunau
P304
P356
10.1542/PEDS.2006-0525
P407
P577
2006-08-28T00:00:00Z